CounterFind, Inc. – Trademark Portfolio

Entity Type: 03

CounterFind, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include COUNTERFIND. The owner is based in Dallas, TX.

1920 McKinney Avenue, 7th Floor

Dallas, TX 75201

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CounterFind, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

45
Legal & Security Services (2 filings)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does CounterFind, Inc. have?

CounterFind, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 4 abandoned.

What trademark classes does CounterFind, Inc. file in?

CounterFind, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are CounterFind, Inc.'s most well-known trademarks?

CounterFind, Inc.'s registered trademark portfolio includes well-known marks such as COUNTERFIND. These are among 2 currently registered trademarks in the portfolio.

What is CounterFind, Inc.'s trademark registration success rate?

CounterFind, Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.